Key Indices


Top Stories
Small/Mid Cap Highlights | Astra Otoparts (AUTO IJ/NOT RATED/Rp3,340)
- AUTO delivered strong 1H26 results, with revenue rising 13.2% yoy to Rp10.8t and net profit increasing 22.6% yoy to Rp1.2t. AUTO expects manufacturing growth to remain intact, while B2C expansion is projected to lift trading margins to 25-26%. AUTO targets 680-690 stores by end-26 and is pursuing a majority-stake acquisition. Its interim dividend rose 22.9% yoy to Rp72.52/share, with further payout increases expected upon M&A completion. BEV components offer long-term upside through relationships with BYD, VinFast and Geely.
Technical Analysis
Mayora Indah | MYOR IJ
- Trading Buy Range: We have a technical Buy at Rp1,465, and take profit at Rp1,540.
Kalbe Farma | KLBF IJ
- Trading Buy Range: We have a technical Buy at Rp785, and take profit at Rp820.
Top Stories
Small/Mid Cap Highlights | Astra Otoparts (AUTO IJ/NOT RATED/Rp3,340)
- AUTO delivered strong 1H26 results, with revenue rising 13.2% yoy to Rp10.8t and net profit increasing 22.6% yoy to Rp1.2t. AUTO expects manufacturing growth to remain intact, while B2C expansion is projected to lift trading margins to 25-26%. AUTO targets 680-690 stores by end-26 and is pursuing a majority-stake acquisition. Its interim dividend rose 22.9% yoy to Rp72.52/share, with further payout increases expected upon M&A completion. BEV components offer long-term upside through relationships with BYD, VinFast and Geely.
Technical Analysis
Mayora Indah | MYOR IJ
- Trading Buy Range: We have a technical Buy at Rp1,465, and take profit at Rp1,540.
Kalbe Farma | KLBF IJ
- Trading Buy Range: We have a technical Buy at Rp785, and take profit at Rp820.
Key Indices


IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.



